BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$2.26
-0.01 (-0.44%)
As of Jun 21, 10:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
195.28M
Net Income
27.48M
Gross Margin
71.5%
Profit Margin
14.1%
Rev Growth
+5.2%
D/E Ratio
9.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 195.28M 185.60M 22.38M 21.94M
Gross Profit 139.55M 132.63M 7.24M 7.09M
Operating Income 36.13M 30.90M 3.89M 4.25M
Net Income 27.48M 23.50M 3.27M 4.37M
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Rev Growth +5.2% +5.2% -5.1% +24.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 38.23M 38.23M 11.22M 12.91M
Total Equity 4.24M 4.24M 63.17M 61.05M
D/E Ratio 9.02 9.02 0.18 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 38.15M 34.44M 5.70M 5.36M
Free Cash Flow 2.62M 2.18M